Chapter 10 Flashcards
(41 cards)
dementia
loss of cognitive ability
Alzheimer’s disease (AD)
- leading cause of dementia
- degeneration of the brain, especially the cortex and limbic system (hippocampus)
- sulci especially wide, indicating degeneration of the cortex
preclinical AD
- no symptoms
- measurable brain changes
mild cognitive impairment due to AD
- very mild symptoms that do not interfere with everyday activities
- measurable brain changes plus subtle problems with memory and thinking
mild AD
- symptoms interfere with some everyday activities
- memory problems (especially new memories), word finding difficulties, trouble with planning/organization
moderate AD
- symptoms interfere with many everyday activities
- memory problems (personal history), feeling moody and/or withdrawn, wandering/getting lost, personality changes (e.g., suspiciousness and delusions)
severe AD
- symptoms interfere with most everyday activities
- loss of awareness (of recent events and surroundings), difficulty with communication, vulnerable to infections (especially pneumonia)
dementia memory lapses
- not recognizing family members
- forgetting to serve meal just prepared
- substituting inappropriate words
- getting lost in own neighborhood
key characteristics of AD
- cognitive deficits: profound memory loss (anterograde/retrograde), language (anomic, empty, circumlocutory), visuospatial disturbance
- behavioral deficits: no significant early changes in personality, unawareness or denial of illness, psychosis
- no sensory or motor deficits
- age of onset 70s-80s
pathology of AD
- neurofibrillary tangles (tau protein)
- amyloid plaques (beta amyloid)
beta-amyloid plaques (senile plaques)
- large amyloid precursor proteins (APP) are cut into fragments called beta-amyloid fragments via the enzyme beta-secretase
- the fragments clump into plaques outside of the cell and destroy dendrites, reducing dendritic branching affecting cognition
- they also initiate an immune response from the microglia that also increase the spread of plaques killing neurons
neurofibrillary tangles
- inside of the neuron
- microtubules are bound together with tau proteins
- if tau proteins change their structure, the microtubules fall apart
- the tau proteins clumps together in tangles, killing the neuron
cytoskeleton of neuron
- gives the neuron its shape
“bones” are: - microtubules: big, run longitudinally down neurites, made of tubulin, microtuble-associated proteins (MAPs) regulate microtuble assembly and function; changes in MAPs called tau implicated in AD
- microfilaments: solid, thinner, actin
- neurofilaments: intermediate filaments, individual long protein molecules
microtubule-associated proteins (MAPs)
- tau/MAPs can function as cross-bridges connecting microtubules
- can affect microtubule rigidity
- brain uses a transport system to help move around the nutrients it needs; system is made of proteins like railroad tracks guiding trains guide nutrients where they need to go; proteins that keep the tracks straight are tau proteins
causes of AD
- genetics (likely several genes)
- immune responses initiated by microglia
- sleep imbalance
genetics of AD
- amyloid precursor protein (APP) (familiar early onset of AD)
- presenilin (PS) 1 and 2 (familial early onset of AD)
- Down’s Trisomy 21
- ApoE4 increases risk of late onset of AD
microglia and AD
- microglia play a role in the immune system and in the brain
- release inflammatory proteins
- attempts to clean up damage caused by beta-amyloid plaques but may contribute to the spread
treatment of AD
- cholinergic replacement: treats symptoms
- anti-amyloid agents: tries to reduce the disease
cholinergic hypothesis
- loss of ACh activity correlates with the severity of AD
- acetylcholinesterase inhibitors: drugs used to treat Alzheimer’s disease, act by inhibiting acetylcholinesterase activity
- these drugs block the esterase-mediated metabolism of acetylcholine to choline and acetate; this results in: increased acetylcholine in the synaptic cleft, increased availability of acetylcholine for postsynaptic and presynaptic nicotinic (and muscarinic) acetylcholine receptors
acetylcholine (ACh)
an important neurotransmitter in areas of the brain involved in memory formation
fronto-temporal dementia (FTD)
- FTD is an umbrella term that encompasses several types of dementia primarily affecting the frontal and temporal lobes of the brain
- includes various subtypes, such as behavioral variant FTD (bvFTD), primary progressive aphasia (PPA), and others
Pick’s disease
- specific subtype of FTD
- characterized by presence of abnormal brain cells known as Pick bodies and Pick cells
- mainly affects the frontal and temporal lobes and typically presents with symptoms similar to behavioral variant FTD
pathology of FTD
- can vary widely and may include tau protein inclusions, TDP-43 inclusions, or other forms of cellular degeneration
- does not always have Pick bodies
pathology of Pick’s disease
characterized specifically by the presence of Pick bodies, which are abnormal clumps of tau protein inside neurons